Spectroscopic measurements of plasma temperatures in a radio frequency dischargeTOMASIK, Z; ZYRNICKI, W.Spectroscopy letters. 1986, Vol 19, Num 2, pp 179-190, issn 0038-7010Article

Spectroscopic measurement of plasma temperatures in a hollow cathode dischargeZYRNICKI, W; TOMASIK, Z; NOWICKA, I et al.Spectroscopy letters. 1984, Vol 17, Num 3, pp 207-217, issn 0038-7010Article

HTLV-1 in Switzerland: low prevalence of specific antibodies in HIV risk groups, high prevalence of cross-reactive antibodies in normal blood donorsSCHUPBACH, J; BAUMGARTNER, A; TOMASIK, Z et al.International journal of cancer. 1988, Vol 42, Num 6, pp 857-862, issn 0020-7136Article

Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival : Comparison with viral RNA measurementLEDERGERBER, B; FLEPP, M; BÖNI, J et al.The Journal of infectious diseases. 2000, Vol 181, Num 4, pp 1280-1288, issn 0022-1899Article

Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infectionNADAL, D; BÖNI, J; KIND, C et al.The Journal of infectious diseases. 1999, Vol 180, Num 4, pp 1089-1095, issn 0022-1899Article

Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1BÜRGISSER, P; VERNAZZA, P; FLEPP, M et al.Journal of acquired immune deficiency syndromes (1999). 2000, Vol 23, Num 2, pp 138-144, issn 1525-4135Article

Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasmaBÖNI, J; OPRAVIL, M; TOMASIK, Z et al.AIDS (London). 1997, Vol 11, Num 6, pp F47-F52, issn 0269-9370Article

Stable human immunodeficiency virus encephalopathy in two infants receiving early intravenous gammaglobulin plus antimicrobial prophylaxisHUNZIKER, U. A; NADAL, D; JENDIS, J. B et al.European journal of pediatrics. 1989, Vol 148, Num 5, pp 417-422, issn 0340-6199, 6 p.Article

Isolation of an in vitro transmissible agent with reverse transcriptase activity from a blood donor with a borderline-positive HIV-1 serology for more than five yearsSCHÜPBACH, J; PYRA, H; JENDIS, J et al.Clinical and diagnostic virology. 1996, Vol 5, Num 2-3, pp 197-203, issn 0928-0197Conference Paper

IgG, IgM, and IgA response to HIV in infants born to HIV-1 infected mothersSCHÜPBACH, J; TOMASIK, Z; JENDIS, J et al.Journal of acquired immune deficiency syndromes. 1994, Vol 7, Num 5, pp 421-427, issn 0894-9255Article

Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failureSCHÜPBACH, J; TOMASIK, Z; NADAL, D et al.International journal of antimicrobial agents. 2000, Vol 16, Num 4, pp 441-445, issn 0924-8579Conference Paper

Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reactionSCHÜPBACH, J; FLEPP, M; PONTELLI, D et al.AIDS (London). 1996, Vol 10, Num 10, pp 1085-1090, issn 0269-9370Article

Immunological evaluation in the early diagnosis of prenatal or perinatal HIV infectionNADAL, D; HUNZIKER, U. A; SCHÜPBACH, J et al.Archives of disease in childhood. 1989, Vol 64, Num 5, pp 662-669, issn 0003-9888Article